Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Allergy and Asthma Reports
Erschienen in: Current Allergy and Asthma Reports 4/2014

01.04.2014 | ALLERGIC SKIN DISEASES (L FONACIER, SECTION EDITOR)

Allergic Contact Dermatitis in Children: Review of the Past Decade

verfasst von: Shehla Admani, Sharon E. Jacob

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Allergic contact dermatitis (ACD) is a type IV delayed hypersensitivity reaction. During the last decade, there has been a heightened awareness of this disease in the pediatric population. The gold standard for diagnosis is patch testing. The prevalence of positive patch tests in referred children with suspected ACD ranges from 27 to 95.6 %. The most common allergens in children in North America are nickel, neomycin, cobalt, fragrance, Myroxylon pereirae, gold, formaldehyde, lanolin/wool alcohols, thimerosal, and potassium dichromate. The relationship between ACD and atopic dermatitis (AD) is complicated with conflicting reports of prevalence in the literature; however, in a patient with dermatitis not responding to traditional therapies, or with new areas of involvement, ACD should be considered as part of the work-up.
Literatur
1.
Jacob SE, and Herro EM. Practical Patch Testing and Chemical Allergens in Contact Dermatitis. Lexington: Springer, 2013. pp 13–20,86,112,113. Print.
2.
Mydlarski PR, Katz AM, Mamelak AJ, et al. Contact Dermatitis. In: Adkinson NF, Yunginger JW, Busse WW, editors. Middleton’s allergy principles and practice. Philadephia: Mosby; 2014. p. 565–79.
3.
Hon KL, Leung AK, Barankin B. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol. 2013;14(5):389–99.PubMedCrossRef
4.
Gimenez-Arnau A, Maurer M, De La Cuadra J, Maibach H. Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". Eur J Dermatol. 2010;20(5):552–62.PubMed
5.
McFadden J. Immunologic contact urticaria. Immunol Allergy Clin N Am. 2014;34(1):157–67.CrossRef
6.
Hjorth N, Roed-Peterson J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis. 1976;2:28–42.PubMedCrossRef
7.
Rieman H, Schwarz T, Grabbe S. Pathomechanisms of the eleicitation phase of allergic contact dermatitis. J Dtsch Dermatol Ges. 2003;1(8):613–9.CrossRef
8.
Janeway C, Travers P, Walport M, Shlomehik M. Immunobiology: the immune system in health and disease. 6th ed. New York: Garland Science Publishing; 2005.
9.
Nijhawen RI, Matic C, Jacob SE. Contact dermatitis: from basics to allergodromes. Pediatr Ann. 2009;38(2):99–108.CrossRef
10.
Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18:385–90.PubMedCrossRef
11.
Elsaie ML, Olasz E, Jacob SE. Cytokines and langerhan cells in allergic contact dermatitis. G Ital Dermatol Venereol. 2008;143(3):195–205.PubMed
12.
Straus HW. Artificial sensitization of infants to poison ivy. J Allergy. 1931;2(3):137–44.CrossRef
13.
Weston WL, Weston JA, Kinoshita J, et al. Prevalence of positive epicutaneous tests among infants, children, and adolescents. Pediatrics. 1986;78(6):1070–4.PubMed
14.
Bruckner AL, Weston WL, Morelli JG. Does sensitization to contact allergens begin in infancy? Pediatrics. 2000;105(1):e3.PubMedCrossRef
15.
Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children--a United States based study. Pediatr Dermatol. 2008;25(5):520–7.PubMedCrossRef
16.
Zug KA, McGinley-Smith D, Warshaw EM, et al. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol. 2008;144(10):1329–36.PubMedCrossRef
17.
Hogeling M, Pratt M. Allergic contact dermatitis in children: the Ottawa hospital patch-testing clinic experience, 1996 to 2006. Dermatitis. 2008;19(2):86–9.PubMed
18.
Jacob SE, Herro EM, Sullivan K, Matiz C, Eichenfield L, Hamann C. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis. 2011;22(4):204–10.PubMed
19.
Jacob SE, Yang A, Herro E, Zhang C. Contact allergens in a pediatric population: association with atopic dermatitis and comparison with other north American referral centers. J Clin Aesthet Dermatol. 2010;3(10):29–35.PubMedCentralPubMed
20.
Lewis VJ, Statham BN, Chowdhury MM. Allergic contact dermatitis in 191 consecutively patch tested children. Contact Dermatitis. 2004;51(3):155–6.PubMedCrossRef
21.
Heine G, Schnuch A, Uter W, Worm M. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis. 2004;51(3):111–7.PubMedCrossRef
22.
Clayton TH, Wilkinson SM, Rawcliffe C, Pollock B, Clark SM. Allergic contact dermatitis in children: should pattern of dermatitis determine referral? A retrospective study of 500 children tested between 1995 and 2004 in one U.K. centre. Br J Dermatol. 2006;154(1):114–7.PubMedCrossRef
23.
Goon AT, Goh CL. Patch testing of Singapore children and adolescents: our experience over 18 years. Pediatr Dermatol. 2006;23(2):117–20.PubMedCrossRef
24.
Beattie PE, Green C, Lowe G, Lewis-Jones MS. Which children should we patch test? Clin Exp Dermatol. 2007;32(1):6–11.PubMed
25.
Onder M, Adisen E. Patch test results in a Turkish paediatric population. Contact Dermatitis. 2008;58(1):63–5.PubMedCrossRef
26.
Jacob SE, Burk CJ, Connelly EA. Patch testing: another steroid-sparing agent to consider in children. Pediatr Dermatol. 2008;25(1):81–7.PubMedCrossRef
27.
de Waard-vander Spek FB, Oranje AP. Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature. Dermatology. 2009;218(2):119–25.CrossRef
28.
Mailhol C, Lauwers-Cances V, Rancé F, Paul C, Giordano-Labadie F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy. 2009;64(5):801–6.PubMedCrossRef
29.
Hammonds LM, Hall VC, Yiannias JA. Allergic contact dermatitis in 136 children patch tested between 2000 and 2006. Int J Dermatol. 2009;48(3):271–4.PubMedCrossRef
30.
Belloni Fortina A, Romano I, Peserico A, Eichenfield LF. Contact sensitization in very young children. J Am Acad Dermatol. 2011;65(4):772–9.PubMedCrossRef
31.
Kuljanac I, Knežević E, Cvitanović H. Epicutaneous patch test results in children and adults with allergic contact dermatitis in Karlovac county: a retrospective survey. Acta Dermatovenerol Croat. 2011;19(2):91–7.PubMed
32.
Schena D, Papagrigoraki A, Tessari G, Peroni A, Sabbadini C, Girolomoni G. Allergic contact dermatitis in children with and without atopic dermatitis. Dermatitis. 2012;23(6):275–80.PubMedCrossRef
33.
Silny W, Bartoszak L, Jenerowicz D, Żukiewicz-Sobczak W, Goździewska M. Prevalence of contact allergy in children suffering from atopic dermatitis, seborrhoeic dermatitis and in healthy controls. Ann Agric Environ Med. 2013;20(1):55–60.PubMed
34.
Worm M, Aberer W, Agathos M, et al. Patch testing in children–recommendations of the German Contact Dermatitis Research Group (DKG). J Dtsch Dermatol Ges. 2007;5(2):107–9.PubMedCrossRef
35.
Jacob SE, Steele T, Brod B, Crawford GH. Dispelling the myths behind pediatric patch testing-experience from our tertiary care patch testing centers. Pediatr Dermatol. 2008;25(3):296–300.PubMedCrossRef
36.
Matiz C, Hsu JW, Paz Castanedo-Tardan M, Jacob SE. Allergic contact dermatitis in children: a review of international studies. G Ital Dermatol Venereol. 2009;144(5):541–56.PubMed
37.
Jacob SE, Breithaupt A. Environmental Exposures- A Pediatric Perspective on Allergic Contact Dermatitis. Skin and, Aging. 2009 Jul:28–36.
38.
Nelson JL, Mowad CM. Allergic Contact Dermatitis: Patch Testing Beyond the TRUE Test. J Clin Aesthet Dermatol. 2010;3(10):36–41.PubMedCentralPubMed
39.
40.
Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol. 2010;76(5):514–20.PubMedCrossRef
41.
Jacob SE, Miller JM, Herro EM. Treating Atopic Dermatitis: Tips for Maintaining an Effective Epidermal Barrier. Skin and, Aging. 2011 Jan:s3–10.
42.
Fonacier LS, Aquino MR, Mucci T. Current strategies in treating severe contact dermatitis in pediatric patients. Curr Allergy Asthma Rep. 2012;12(6):599–606.PubMedCrossRef
43.
“Thimerosal and 2013–2014 Seasonal Flu Vaccines”. Centers for Disease Control and Prevention. CDC, 3 Sep 2013. Web. 12 Dec 2013.
44.
Nijhawan RI, Jacob SE. Connubial dermatitis revisited: mother-to-child contact dermatitis. Dermatitis. 2009;20:55–7.PubMed
45.
Hsu JW, Matiz C, Jacob SE. Nickel allergy: localized, id, and systemic manifestations in children. Pediatr Dermatol. 2011;28(3):276–80.PubMedCrossRef
46.
Nijhawan RI, Molenda M, Zirwas MJ, Jacob SE. Systemic contact dermatitis. Dermatol Clin. 2009;27:355–64.PubMedCrossRef
47.
Szyfelbein Masterpol K, Gottlieb AB, Scheinman PL. Systemic contact dermatitis presenting as lichen planus of the lip. Dermatitis. 2010;21:218–319.PubMed
48.
Wentworth AB, Yiannias JA, Keeling JH, et al. Trends in patch-test results and allergen changes in the standard series: A Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010). J Am Acad Dermatol. 2013 Nov 20.
49.
Warshaw EM, Belsito DV, Taylor JS, et al. North American Contact Dermatitis Group patch test results: 2009 to 2010. Dermatitis. 2013;24(2):50–9.PubMedCrossRef
50.
51.
Jacob SE, Stechschulte S. Eyelid dermatitis associated with balsam of Peru constituents: benzoic acid and benzyl alcohol. Contact Dermatitis. 2008;58(2):111–2.PubMedCrossRef
52.
Morioka Y, Yamasaki K, Leung D, Gallo RL. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis. J Immunol. 2008;181(6):3915–22.PubMedCentralPubMedCrossRef
53.
Di Nardo A, Braff MH, Taylor KR, et al. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol. 2007;178(3):1829–34.PubMedCrossRef
54.
Hanifin JM. Filaggrin mutations and allergic contact sensitization. J Invest Dermatol. 2008;128(6):1362–4.PubMedCrossRef
55.
Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164(5):2405–11.PubMedCrossRef
56.
Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol. 1989;125(3):366–8.PubMedCrossRef
57.
Lobitz Jr WC, Honeyman JF, Winkler NW. Suppressed cell-mediated immunity in two adults with atopic dermatitis. Br J Dermatol. 1972;86(4):317–28.PubMedCrossRef
58.
Newell L, Polak ME, Perera J, et al. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol. 2013;133(10):2372–80.PubMedCrossRef
59.
Lammintausta K, Kalimo K, Fagerlund VL. Patch test reactions in atopic patients. Contact Dermatitis. 1992;26(4):234–40.PubMedCrossRef
60.
Belhadjali H, Mohamed M, Youssef M, Mandhouj S, Chakroun M, Zili J. Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia. Contact Dermatitis. 2008;58(3):188–9.PubMedCrossRef
61.
Oranje AP, Bruynzeel DP, Stenveld HJ, Dieges PH. Immediate- and delayed-type contact hypersensitivity in children older than 5 years with atopic dermatitis: a pilot study comparing different tests. Pediatr Dermatol. 1994;11(3):209–15.PubMedCrossRef
62.
Holden CR, Gawkrodger DJ. 10 years' experience of patch testing with a shoe series in 230 patients: which allergens are important? Contact Dermatitis. 2005;53(1):37–9.PubMedCrossRef
63.
Cronin H, Mowad C. Anaphylactic reaction to bacitracin ointment. Cutis. 2009;83(3):127–9.PubMed
64.
Usmani N, Wilkinson SM. Allergic skin disease: investigation nof both immediate- and delayed-type hypersensitivity is essential. Clin Exp Allergy. 2007;37(10):1541–6.PubMed
65.
Roul S, Ducombs G, Taieb A. Usefulness of the European standard series for patch testing in children. A 3-year single-centre study of 337 patients. Contact Dermatitis. 1999;40(5):232–5.PubMedCrossRef
66.
Fisher AA. Childhood allergic contact dermatitis. Cutis. 1975;15:635–42.
67.
Package insert for Thin-Layer Rapid Use Epicutaneous Patch Test (T.R.U.E.)™, Smart Practice; Phoenix, Arizona. February 2012.
68.
Wahlberg JE. Patch testing. In: Rycroft RJG, Menne T, Frosch PJ, Lepoittevin JP, editors. Textbook of contact dermatitis. 3rd ed Berlin: springer-Verlag; 2001. Pp. 435–68.
69.
Anveden I, Lindberg M, Andersen KE, et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis. 2004;50(5):298–303.PubMedCrossRef
70.
Fowler Jr JF, Maibach HI, Zirwas M, et al. Effects of immunomodulatory agents on patch testing: expert opinion 2012. Dermatitis. 2012;23(6):301–3.PubMedCrossRef
71.
Torchia D, Capretti C, Pizzo B, Francalanci S. Patch test triggering recurrence of distant dermatitis: the flare-up phenomenon. CMAJ. 2008;179(4):341.PubMedCentralPubMedCrossRef
72.
Fisher AA. Perfume dermatitis in children sensitized to balsam of Peru in topical agents. Cutis. 1990;45(1):21–3.PubMed
73.
Gelpi CB, Jacob SE. Instructions for educating patients on ROAT testing in conjunction with patch testing. Dermatol Nurs. 2008;20(2):139–43.PubMed
74.
Rajagopalan R, Anderson R. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis. Am J Contact Dermatitis. 1997;8:215–21.PubMedCrossRef
Metadaten
Titel
Allergic Contact Dermatitis in Children: Review of the Past Decade
verfasst von
Shehla Admani
Sharon E. Jacob
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 4/2014
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-014-0421-0

Weitere Artikel der Ausgabe 4/2014

Current Allergy and Asthma Reports 4/2014 Zur Ausgabe

ALLERGENS (RK BUSH AND JA WOODFOLK, SECTION EDITORS)

Cross-Reactivity of Peanut Allergens

BASIC AND APPLIED SCIENCE (M FRIERI AND PJ BRYCE, SECTION EDITORS)

Interleukin-31: A Novel Diagnostic Marker of Allergic Diseases

OCCUPATIONAL ALLERGIES (JA POOLE, SECTION EDITOR)

Occupational Irritant and Allergic Rhinitis

RHINITIS (JJ OPPENHEIMER AND J CORREN, SECTION EDITORS)

New Therapies for Allergic Rhinitis

ALLERGENS (RK BUSH AND JA WOODFOLK, SECTION EDITORS)

Recombinant Allergens for Diagnosis of Cockroach Allergy

RHINOSINUSITIS (J MULLOL, SECTION EDITOR)

Evidence-based Surgery for Chronic Rhinosinusitis with and without Nasal Polyps

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise